Serotonin syndrome induced by the readministration of escitalopram after a short-term interruption in an elderly woman with depression: a case report
Yasushi Sato,1,2 Kazuhiko Nakamura,1 Norio Yasui-Furukori1 1Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Hirosaki, Japan; 2Department of Psychiatry, Tsugaru General Hospital, Goshogawara, Japan Background: Serotonin syndrome is a rare but potentially fatal side ef...
Guardado en:
Autores principales: | Sato Y, Nakamura K, Yasui-Furukori N |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d12d3c3c750d49439d02e9b263b7b1e4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparative efficacy of escitalopram in the treatment of major depressive disorder
por: Mazen K Ali, et al.
Publicado: (2011) -
A positive correlation between serum amyloid β levels and depressive symptoms among community-dwelling elderly individuals in Japan
por: Tsuruga K, et al.
Publicado: (2014) -
Efficacy and safety of generic escitalopram (Lexacure®) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram-comparative, non-inferiority study
por: Jeong JH, et al.
Publicado: (2015) -
Escitalopram, bupropion, lurasidone, lamotrigine and possible vortioxetine overdose presented with serotonin syndrome and diffuse encephalopathy: A case report
por: Suthimon Thumtecho, et al.
Publicado: (2021) -
Long-term administration of escitalopram in patients with social anxiety disorder in Japan
por: Asakura S, et al.
Publicado: (2016)